|
Patient characteristics in both intervention and comparison VHA hospitals at baseline |
|||
| Patient characteristics |
Intervention |
Comparison |
p-value |
|
|
|||
| N = 2372 |
N = 3066 |
||
|
|
|||
| Mean age |
69.0 (s.d. 10.3) |
70.7 (s.d. 9.6) |
<0.001 |
| % male |
98.2 |
98.6 |
0.02 |
| % white |
66% |
68% |
0.02 |
| % income less than $20,000 per year |
62% |
55% |
<0.001 |
| Mean number of comorbidities |
0.99 (s.d. 1.01) |
0.98 (s.d.0.98) |
0.68 |
| % with current LDL-c at baseline |
91.2% |
94.0% |
<0.001 |
| % on lipid lowering agents at baseline among IHD patients with LDL-c > 130 mg/dL |
79.6% |
80.2% |
0.884 |
Sales et al. Implementation Science 2008 3:28 doi:10.1186/1748-5908-3-28 |
|||